Literature DB >> 24256945

Two surfaces of cytochrome b5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries.

Hwei-Ming Peng1, Richard J Auchus2.   

Abstract

Conserved human cytochrome b5 (b5) residues D58 and D65 are critical for interactions with CYP2E1 and CYP2C19, whereas E48 and E49 are essential for stimulating the 17,20-lyase activity of CYP17A1. Here, we show that b5 mutations E48G, E49G, D58G, and D65G have reduced capacity to stimulate CYP3A4-catalyzed progesterone and testosterone 6β-hydroxylation or nifedipine oxidation. The b5 double mutation D58G/D65G fails to stimulate these reactions, similar to CYP2E1 and CYP2C19, whereas mutation E48G/E49G retains 23-42% of wild-type stimulation. Neither mutation impairs the activity stimulation of wild-type b5, nor does mutation D58G/D65G impair the partial stimulation of mutations E48G or E48G/E49G. For assays reconstituted with a single phospholipid, phosphatidyl serine afforded the highest testosterone 6β-hydroxylase activity with wild-type b5 but the poorest activity with b5 mutation E48G/E49G, and the activity stimulation of mutation E48G/E49G was lost at [NaCl]>50mM. Cross-linking of CYP3A4 and b5 decreased in the order wild-type>E48G/E49G>D58G/D65G and varied with phospholipid. We conclude that two b5 acidic surfaces, primarily the domain including residues D58-D65, participate in the stimulation of CYP3A4 activities. Our data suggest that a minor population of CYP3A4 molecules remains sensitive to b5 mutation E48G/E49G, consistent with phospholipid-dependent conformational heterogeneity of CYP3A4.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allostery; CYP3A4; Cytochrome P450; Cytochrome b(5); Drug oxidation; Testosterone

Mesh:

Substances:

Year:  2013        PMID: 24256945      PMCID: PMC3933929          DOI: 10.1016/j.abb.2013.11.001

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  40 in total

1.  High-level expression in Escherichia coli and purification of the membrane-bound form of cytochrome b(5).

Authors:  S B Mulrooney; L Waskell
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

Review 2.  Atypical kinetic profiles in drug metabolism reactions.

Authors:  J Matthew Hutzler; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2002-04       Impact factor: 3.922

3.  Elucidation of distinct ligand binding sites for cytochrome P450 3A4.

Authors:  N A Hosea; G P Miller; F P Guengerich
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

4.  Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity.

Authors:  T L Domanski; Y A He; K K Khan; F Roussel; Q Wang; J R Halpert
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

5.  Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Authors:  Hiroshi Yamazaki; Mami Nakamura; Tomoko Komatsu; Katsuhiro Ohyama; Naoya Hatanaka; Satoru Asahi; Noriaki Shimada; F Peter Guengerich; Tsutomu Shimada; Miki Nakajima; Tsuyoshi Yokoi
Journal:  Protein Expr Purif       Date:  2002-04       Impact factor: 1.650

6.  Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.

Authors:  Kishore K Khan; You Qun He; Tammy L Domanski; James R Halpert
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

7.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

8.  CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.

Authors:  Daniel P Sherbet; Dov Tiosano; Kerri M Kwist; Zeev Hochberg; Richard J Auchus
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

Review 9.  The many roles of cytochrome b5.

Authors:  John B Schenkman; Ingela Jansson
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

10.  The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65.

Authors:  Hwei-Ming Peng; Richard J Auchus
Journal:  Biochemistry       Date:  2012-12-17       Impact factor: 3.162

View more
  5 in total

1.  Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.

Authors:  Hwei-Ming Peng; Jiayan Liu; Sarah E Forsberg; Hong T Tran; Sean M Anderson; Richard J Auchus
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

2.  Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

3.  Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.

Authors:  Hwei-Ming Peng; Chase Barlow; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2018-03-13       Impact factor: 4.292

4.  Ligand accessibility to heme cytochrome b5 coordinating sphere and enzymatic activity enhancement upon tyrosine ionization.

Authors:  Alejandro K Samhan-Arias; Cristina M Cordas; Marta S Carepo; Luisa B Maia; Carlos Gutierrez-Merino; Isabel Moura; José J G Moura
Journal:  J Biol Inorg Chem       Date:  2019-03-05       Impact factor: 3.358

Review 5.  Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.

Authors:  Sylvie E Kandel; Jed N Lampe
Journal:  Chem Res Toxicol       Date:  2014-08-29       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.